Investorideas.com - #Cannabisstocks: Organigram (TSX VENTURE: $OGI.V) (OTCQX: $OGRMF) signs supply agreement with Newfoundland and Labrador Liquor Corporation
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Friday, September 14, 2018
Investorideas.com - #Cannabisstocks: Aurora Cannabis (TSX: $ACB.TO) (OTCQB: $ACBFF) Provides Update on Australis Capital Public Listing
Investorideas.com - #Cannabisstocks: Aurora Cannabis (TSX: $ACB.TO) (OTCQB: $ACBFF) Provides Update on Australis Capital Public Listing
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - CSE New #Cannabis Listing: Australis Capital Inc. (AUSA and AUSA.WT); @CSE_News
Investorideas.com - CSE New #Cannabis Listing: Australis Capital Inc. (AUSA and AUSA.WT); @CSE_News
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - #Cannabisstocks: PUF Ventures (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF) Announces Greenhouse Project Update and Proposed Issuance of Shares
Investorideas.com - #Cannabisstocks: PUF Ventures (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF) Announces Greenhouse Project Update and Proposed Issuance of Shares
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Investorideas.com - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $OGI.V, TSX: $ACB.TO, CSE: $MDM.C
Investorideas.com - Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $OGI.V, TSX: $ACB.TO, CSE: $MDM.C
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $OGI.V, TSX: $ACB.TO, CSE: $MDM.C
Delta, Kelowna, BC - September 14, 2018 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its "potcast" site, www.potcasts.ca release today's edition of its series, Investorideas.com potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: TSXV: $OGI.V, TSX: $ACB.TO, CSE: $MDM.C
Today's podcast overview/transcript:
Good morning and welcome to another Investorideas.com potcast - looking at cannabis news, stocks to watch as well as insights from thought leaders and experts.
Today we will be looking at announcements from Organigram Holdings Inc. trading on the TSX VENTURE as OGI, Aurora Cannabis Inc. trading on the TSX as ACB and the OTCQB as ACBFF and Marapharm Ventures Inc. trading on the CSE as MDM,
Organigram Holdings Inc., the parent company of Organigram Inc., a leading licensed producer of medical marijuana, updated the market on its proposed investment in Eviana Health Corporation. This information is meant to update and replace the information previously disseminated by Organigram on June 4, 2018 regarding a proposed investment in Eviana.
Organigram has signed a term sheet to participate as to 50% in a private placement debenture offering by Eviana comprised of 10,000 debenture units of Eviana, each consisting of: (i) $1,000 principal amount of senior unsecured convertible debentures of Eviana and (ii) one half of one common share purchase warrant of the Company. The balance of the Debenture Offering is proposed to be acquired by an institutional strategic investor.
Each full Warrant shall be exercisable by the holder thereof for 870 Common Shares in the capital of Eviana at an exercise price per Warrant Share of $1.30 for a period of 24 months from the closing date of the Debenture Offering. The Debentures will be convertible at a conversion price of $1.15 per Common Share at the holder's option, or upon mandatory conversion at the request of Eviana in the event that at any time following four months plus one day following the Closing, for any ten consecutive trading days, the daily volume weighted average closing price of the Common Shares on the CSE is greater than $2.15.
The Debenture Offering is expected to be completed on or about September 27, 2018, or such earlier or later date as the Strategic Investor, Organigram and Eviana may determine.
Organigram Holdings Inc. also announced that the Company has signed a supply agreement with the Newfoundland and Labrador Liquor Corporation (NLC) in anticipation of the launch of a legal, adult use recreational cannabis market in the province.
"We are pleased to have been accepted as a supplier to NLC," says Greg Engel, Organigram's Chief Executive Officer. "At Organigram, we are very proud of our Atlantic Canadian roots and the opportunities we have to offer our neighbours a broad choice of high-quality cannabis products."
According to the terms of the agreement, Newfoundland and Labrador cannabis retailers will have access to almost 100% of Organigram's entire product portfolio. Organigram will also play a role in the province's e-commerce plans, allowing for consumers to order directly on-line.
Aurora Cannabis Inc. and Australis Capital Inc. today announced the common shares and warrants of Australis are expected to commence trading on the Canadian Securities Exchange under the trading symbol "AUSA" at the opening of trading on September 19, 2018 immediately following the completion of the distribution of Units by Aurora to its shareholders.
To date, the medical use of cannabis is legal in 31 states, the District of Columbia and the territories of Guam and Puerto Rico. Nine states plus the District of Columbia have proceeded with consumer legalization. While momentum continues to build at the state level, cannabis remains a Schedule 1 controlled substance at the under the federally governed Controlled Substances Act. Consequently, the U.S. cannabis market is fragmented in nature and includes many high-quality operations and technology innovators with limited access to capital. This has created a compelling opportunity for well capitalized Canadian companies to invest in U.S. assets, especially considering anticipated market growth, with over 50% of the U.S. population currently living in states with legal access.
Recent changes in U.S. federal positioning with respect to cannabis have positively impacted the perception of risk to invest in U.S. cannabis assets. This has further incentivized capital market participants to seek opportunities to fund U.S. based operations.
Australis synthesizes decades of relevant expertise, its strong historical relationship with Aurora Cannabs and other strategic relationships, and capital investment execution to build value in the cannabis value chain in the United States. Targeting investments in cannabis and associated real estate opportunities, Australis is well positioned for early-stage access to attractively priced opportunities. Following an oversubscribed, non-brokered private placement, raising gross proceeds of $17 million, Australis is aggressively identifying high quality investment opportunities with strong growth potential. Australis has assembled a management team with significant U.S. capital markets, operating and regulatory compliance experience governed by an industry best board of directors and deeply rooted cannabis investment advisory committee.
Through aggressive and disciplined investment, access to capital markets, Australis will leverage strategic relationships with Aurora Cannabis and others to maximize deal flow and discounted investments.
Marapharm Ventures Inc. reported that Green Leaf Wellness Dispensary made profitable progress during the six-month California regulatory transition period to MAUCRSA (Medicinal and Adult-Use Cannabis Regulation and Safety Act).
During the transition period, January 1, 2018 to June 30, 2018, cannabis businesses were forced to sell their inventory of noncompliant flower, edibles and concentrates before the new stringent regulations of July 1, 2018; after which date all noncompliant products would have to be destroyed.
Management and staff at Green Leaf Wellness Dispensary took exemplary measures to prepare for the new regulations and have shown increase to profits and higher traffic volumes.
Their Manager was pre-emptive, placing orders for compliant product well in advance and ensuring its delivery by July 1st. In addition, restructuring the marketing of noncompliant product prior to the deadline with minimal loss to the dispensary.
Many dispensaries in the surrounding area suffered losses and were forced to close, due to lack of planning and access to compliant product. The United Cannabis Business Association (UCBA) estimated $400 million in losses of unsold and destroyed cannabis in California after July 1, 2018.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, iHeartradio, Spreaker and Tunein.
If you would like to be a guest or sponsor this podcast contact Investorideas.com
Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment
Subscribe to the new cannabis podcast series:
To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708
Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . Investorideas.com original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column and the Cleantech and Climate Change Podcast.
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp.
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.
Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Canada’s #Marijuana Legalization Date of Oct 17th Nears; Investor Ideas Updates #Cannabis / #Hemp #Stock Directory for #Investors and #Traders
Canada’s #Marijuana Legalization Date
of Oct 17th Nears; Investor
Ideas Updates #Cannabis / #Hemp #Stock Directory
for #Investors and #Traders
Delta, Kelowna, BC –September 14, 2018
(Investorideas.com Newswire) www.Investorideas.com, a global news source
covering leading sectors including marijuana and hemp stocks and its “potcast’
site, www.potcasts.ca , Investor Ideas #Potcasts #Cannabis News and Stocks
on the Move, issue the following stock directory preview and update for
investors and traders following the sector as the Canadian cannabis legalization date of Oct 17
is nearing.
Investor Ideas
stock directory of publicly traded CSE, TSX, TSXV,
OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Read this in full at https://www.investorideas.com/news/2018/cannabis/09141Stocks.asp
Marijuana/Hemp Stocks 2018 Preview
Aphria Inc (TSX: APH.TO; OTC:APHQF) Aphria is a leading global cannabis company
driven by an unrelenting commitment to our people, product quality and
innovation. Headquartered in Leamington, Ontario – the greenhouse capital of
Canada – Aphria has been setting the standard for the low-cost production of
safe, clean and pure pharmaceutical-grade cannabis at scale, grown in the most
natural conditions possible. Focusing on untapped opportunities and backed by
the latest technologies, Aphria is committed to bringing breakthrough
innovation to the global cannabis market. The Company's portfolio of brands is
grounded in expertly-researched consumer insights designed to meet the needs of
every consumer segment. Rooted in our founders' multi-generational expertise in
commercial agriculture, Aphria drives sustainable long-term shareholder value
through a diversified approach to innovation, strategic partnerships and global
expansion, with a presence in more than 10 countries across 5 continents
Arkados Group, Inc. (OTC:AKDS) through its subsidiaries, is a global
provider of scalable and interoperable Internet of Things solutions focused on
industrial automation and energy management. We execute our business as a
software developer and energy services firm focused on developing unique,
cutting-edge solutions that enable machine to machine communications with
specific applications for building and machine automation. Arkados, Inc., our
technology subsidiary, has developed the Arktic™ software platform, a scalable
and interoperable cloud-based system for sensing, gathering, storing, analyzing
data as well as reporting critical information and implementing command and
control. Our applications currently focus on measurement and verification and
predictive analytics and are expanding to include building and city automation.
Arkados Energy Solutions, our services subsidiary, is a general contractor
providing energy conservation services to commercial building owners and
managers. These services include energy assessments, LED lighting retrofits,
oil-to-natural gas boiler conversions and solar PV system installations. The
companies combine to provide solutions to building owners that increase return
on investment, reduce operational cost and save energy. Arkados® is a
registered trademark of Arkados Group, Inc. Cannabis: April 2017: beta site
agreement with Yuma Way LLC, a Colorado-based cannabis grower, to utilize the
Arktic™ Smart Building solution to help to optimize conditions in their
greenhouse facility in order to increase revenues and reduce operating
expenses.
Arena Pharmaceuticals, Inc. (NasdaqGS:ARNA) a biopharmaceutical company,
discovers, develops, and commercializes novel drugs that target G
protein-coupled receptors. The company offers BELVIQ, a drug used to treat
chronic weight management in adults. One of the products under development is
APD371, an agonist of the cannabinoid receptor 2 that is in Phase I
single-ascending dose trial for the treatment of pain. The company also
manufactures drug products under a manufacturing services agreement for
Siegfried AG
Ascent Industries Corp. (CSE: ASNT) In Canada,
Ascent (through its wholly-owned subsidiaries) is a Licenced Producer under the
Access to Cannabis for Medical Purposes Regulations of Health Canada, with
licences to cultivate cannabis and produce cannabis extracts. In addition, the
Company is a Licenced Dealer under the Controlled Drugs and Substances Act
(Canada), with the ability to produce, package, sell, send, transport and
distribute medically focused cannabis products in Canada to other licenced
entities and internationally in jurisdictions where medical cannabis is legal.
In the United States, the Company holds licences in Oregon (for processing and
for distribution of cannabis to any licenced entity in the state) and in Nevada
(for cultivation and for production, processing and wholesale distribution of
cannabis). In Europe, Agrima ApS, a Danish company and wholly-owned subsidiary
of Ascent, has submitted licence applications for a Wholesaler Dealers Licence
and Controlled Drug Licence in Denmark, and applications for the approval of
eight products to the Danish Medical Cannabis Pilot Program.
Aurora
Cannabis Inc.
(TSX:ACB.V; OTC:
ACBFF) Headquartered in Edmonton, Alberta, Canada with
funded capacity in excess of 570,000 kg per year and sales and operations in 14
countries across five continents, Aurora is one of the world's largest and
leading cannabis companies. Aurora is vertically integrated and horizontally
diversified across every key segment of the value chain, from facility
engineering and design to cannabis breeding and genetics research, cannabis and
hemp production, derivatives, high value-add product development, home
cultivation, wholesale and retail distribution. Highly differentiated from its
peers, Aurora has established a uniquely advanced, consistent and efficient
production strategy, based on purpose-built facilities that integrate
leading-edge technologies across all processes, defined by extensive automation
and customization, resulting in the massive scale production of high quality
product at ultra-low costs. Intended to be replicable and scalable globally,
these production facilities are designed to produce cannabis of significant
scale, with high quality, industry-leading yields, and ultra-low per gram
production costs. Each of Aurora's facilities is built to meet European Union
(EU) GMP standards, and its first production facility, the recently acquired
MedReleaf Markham facility, and its wholly owned European medical cannabis
distributor Pedanios, have achieved this level of certification. In addition to
the Company's rapid organic growth and strong execution on strategic M&A,
which to date includes 10 companies acquired – MedReleaf, CanvasRx, Peloton
Pharmaceutical, Pedanios, H2 Biopharma, Urban Cultivator, BC Northern Lights,
Larssen Greenhouses, CanniMed Therapeutics, and Anandia – Aurora is
distinguished by its reputation as a partner of choice and employer of choice
in the global cannabis sector, having invested in and established strategic
partnerships with a range of leading innovators, including: The Green Organic
Dutchman Holdings Ltd. (TSX:TGOD.TO - News), Radient Technologies
Inc. (TSXV:RTI.V - News), Hempco Food and Fiber
Inc. (TSXV:HEMP.V - News), Cann Group Ltd. (ASX:CAN.AX - News), Micron Waste
Technologies Inc. (CSE:MWM), Choom Holdings Inc. (CSE:CHOO), Namaste
Technologies Inc. (TSXV:N.V - News), Evio Beauty Group
(private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC:CTTH - News), Capcium Inc. (private),
and Alcanna Inc. (TSX:CLIQ.TO - News).
AusCann Group (ASX:AC8.AX) researches, develops, cultivates, produces, and sells
clinically validated cannabis medicines to patients in Australia. The company
has a strategic partnership with Tasmanian Alkaloids Pty Ltd. AusCann Group
Holdings Ltd is headquartered in Carabooda, Australia.
Auxly Cannabis Group Inc. (TSX:XLY.V) is a collective of entrepreneurs with a passion for
the cannabis industry past, present and future. Our mandate is to facilitate
growth for our partners by providing them with financial support and sharing
our collective industry experience. Our partners all have different visions,
voices and brand values, and all share a common goal—to build a world-class
industry based on ethics, diversity, quality and innovation.
Axim Biotechnologies Inc (OTC:AXIM) focuses on the research, development and
production of cannabis-based pharmaceutical, nutraceutical and cosmetic
products. Our flagship products include CanChew®, a CBD-based controlled
release chewing gum, and MedChew Rx, a combination CBD/THC gum that is
undergoing clinical trials for the treatment of pain and spasticity associated
with multiple sclerosis. We prioritize the well-being of our customers while
embracing a solid fiscal strategy.
Bang Holdings Corp (OTC:BXNG) through its
subsidiary Bang Digital Media, provides brand management, cannabis related
digital content and influencer-based marketing for the cannabis industry. While
major media providers restrict online marijuana advertising, Bang Holdings’
marketing networks allow cannabis companies to directly reach cannabis and
cannabis equipment consumers. Since launching its first digital channel
4TwentyToday across multiple digital platforms in 2014, Bang Digital Media’s
network has grown to reach more than a million engaged enthusiasts and has
generated hundreds of millions of content views. Bang’s expanded network of
cannabis-friendly social influencers reaches an additional twenty million
subscribers.
Bedrocan Cannabis Corp (TSX:BED.V) is the global leader in medicinal cannabis research and
product innovation and has been producing and supplying government-regulated
medicinal cannabis for 13 years. Bedrocan’s strains of pharmaceutical-grade
cannabis are used by patients in seven countries, including Canada. The company
is committed to clinical research, with ISO 9001-rated production processes and
product development, on an international scale. Bedrocan is one of only two
companies currently supplying pharmaceutical-grade medicinal cannabis in
Canada.
Beleave Inc. (CSE:BE; OTC:BLEVF) Beleave
is a biotech company who's wholly-owned subsidiary Beleave Kannabis Corp. is
licensed to cultivate and sell medical cannabis and produce cannabis oils and
extracts pursuant to Health Canada's Access to Cannabis for Medical Purpose
Relations. Beleave has developed a network of medical cannabis clinics under
the Medi-Green banner and has applied for various patents to broaden its strong
research focused foundation.
Get the full list as an Investor ideas member , plus get weekly updates
with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more https://www.investorideas.com/membership/
Investor Ideas stock directory of publicly traded CSE, TSX,
TSXV, OTC, NASDAQ, NYSE, ASX Marijuana / Hemp Stocks
Investor Ideas #Potcasts #Cannabis News and Stocks on the
Move:
Subscribe to the new cannabis podcast series:
Investorideas.com podcasts are also available on
iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified word
mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that Inspires
Big Investing Ideas
Investorideas.com is a recognized news source
publishing third party news and press releases plus we create original
financial content. Learn about investing in stocks and sector trends
from Investorideas.com with our news alerts , articles , podcasts and videos talking about cannabis, crypto,
technology including AI and IoT ,
mining ,sports biotech, water, renewable energy and more . Investorideas.com
original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and
stock news column, Investor
Ideas #Potcasts #Cannabis News
and Stocks on the Move podcast and column,
Cleantech and Climate Change Podcast and
the Stock Guru daily podcast on Support and Resistance Trading.
Disclaimer/Disclosure: Investorideas.com is
a digital publisher of third party sourced news, articles and equity research
as well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp.
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info:
https://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations
of each country.
Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Follow us on Social Media
Contact Investorideas.com
800-665-0411
Thursday, September 13, 2018
Investorideas.com - #Cannabisstocks: CannaRoyalty (CSE: CRZ) (OTCQX: CNNRF) Provides Strategic Financing to Brand Partner Utopia Cannabis to Drive Revenue Growth
Investorideas.com - #Cannabisstocks: CannaRoyalty (CSE: CRZ) (OTCQX: CNNRF) Provides Strategic Financing to Brand Partner Utopia Cannabis to Drive Revenue Growth
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Subscribe to:
Posts (Atom)